Skip to Content
 

News: T.J. Martell Foundation

Chic Awearness event supports VUMC ovarian cancer research

Sunday, September 17th, 2017

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.

HDAC3 role in B-cell development

Monday, August 7th, 2017

Histone deacetylases (HDACs) are enzymes that modulate gene expression and have important roles in development and disease. HDAC inhibitors are active against lymphoma, and understanding the roles of specific HDACs is important for further therapeutic development. Scott Hiebert, Ph.D., and colleagues used a mouse model to explore the role of HDAC3 in the early development […]

VICC racers compete in downtown bed race for cancer research funding

Thursday, June 15th, 2017

Staff members from Vanderbilt-Ingram Cancer Center (VICC) garnered an impressive second place finish in last month’s Downtown Derby Bed Race competition. The annual event which raises funds for the T.J. Martell Foundation featured teams that built and decorated their own “beds” to race up 5th Avenue to Bridgestone Plaza in downtown Nashville. The VICC team, […]

Vanderbilt mourns loss of philanthropist Tony Martell

Thursday, December 8th, 2016

Members of the Vanderbilt community are mourning the loss of music executive and health care philanthropist Tony Martell, who died Sunday, Nov. 27, at his home in New Jersey. He was 90. Tony Martell Mr. Martell, a prominent music industry executive, became committed to supporting medical research after the death of his son, T.J., who […]

New software tracks cancer mutations, survival

Thursday, June 2nd, 2016

Malignant tumors are increasingly subject to routine clinical genotyping, primarily to predict drug response or assist with prognosis. A team at Vanderbilt University Medical Center (VUMC) has developed and tested software that scans electronic health records in real time to monitor cancer patient survival (from time of diagnosis) according to which genes, if any, are […]

T.J. Martell Foundation lauds Pietenpol’s research

Thursday, March 17th, 2016

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel. The Medical Research Advancement Award is in recognition of Pietenpol’s career as a cancer researcher. […]

Study suggests cancer’s ‘clock’ can be rewound

Thursday, March 17th, 2016

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented. “This was totally unexpected,” said James Goldenring, M.D., Ph.D., the Paul W. Sanger Professor of Experimental […]

New lead for ovarian cancer treatment

Friday, December 11th, 2015

Despite increasingly advanced treatments, nearly half the women who contract ovarian cancer will die within five years. Chemotherapy drug resistance significantly contributes to the high mortality rate. Understanding the processes that trigger tumor growth allows scientists to find better ways to treat this disease. Members of the laboratory of Hal Moses, M.D., previously identified the […]